Modulation of Microbiota‐Derived Bile Acids Linked to Symptom Amelioration in Crohn's Disease: Insights From a Randomized Clinical Trial With Xanthohumol Supplementation

Documenti analoghi

• Safety and Tolerability of Xanthohumol in Adults With Crohn's Disease: Results of a Triple‐Masked, Randomized, Placebo‐Controlled Phase 2 Trial
  di: Ryan Bradley, et al.
  Pubblicazione: (2026)
• Dietary Supplementation with Nervonic Acid Ameliorates Cerebral Ischemia‐Reperfusion Injury by Modulating of Gut Microbiota Composition‐Fecal Metabolites Interaction
  di: Hui Zhou, et al.
  Pubblicazione: (2024)
• Palmitoleic Acid Ameliorates Metabolic Disorders and Inflammation by Modulating Gut Microbiota and Serum Metabolites
  di: Junhui Zhang, et al.
  Pubblicazione: (2024)
• Intermittent Fasting Improves Insulin Resistance by Modulating the Gut Microbiota and Bile Acid Metabolism in Diet‐Induced Obesity
  di: Sha Lei, et al.
  Pubblicazione: (2024)
• The Promoting Effects of Fermented Bile Acid on Growth Performance and Intestinal Health of Litopenaeus vannamei Through the Modulation of Lipid Metabolism and Gut Microbiota
  di: Qing Guo, et al.
  Pubblicazione: (2025)